Females | Males | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
N | % | % series completed | Unadjusted OR (95% CI) | Adjusteda OR (95% CI) | N | % | % series completed | Unadjusted OR (95% CI) | Adjusteda OR (95% CI) | |
Age of first dose (years) | ||||||||||
9–14 | 96,702 | 49.7 | 30.8 | 1 | 1 | 72,071 | 38.2 | 29.7 | 1 | 1 |
15–18 | 56,407 | 29.0 | 26.8 | 0.83 (0.81–0.84) | 0.79 (0.77–0.81) | 87,336 | 46.2 | 28.6 | 0.95 (0.93–0.97) | 0.86 (0.85–0.88) |
19–26 | 41,298 | 21.2 | 21.1 | 0.60 (0.59–0.62) | 0.58 (0.56–0.59) | 29,483 | 15.6 | 21.9 | 0.66 (0.64–0.68) | 0.60 (0.58–0.62) |
Insurance type | ||||||||||
Medicaid | 28,827 | 14.8 | 17.6 | 1 | 1 | 22,588 | 12.0 | 17.8 | 1 | 1 |
Private | 165,580 | 85.2 | 29.3 | 1.94 (1.88–2.01) | 2.60 (2.08–3.24) | 166,302 | 88.0 | 29.4 | 1.93 (1.88–2.00) | 1.93 (1.86–2.01) |
Year of first dose | ||||||||||
2009b | 3565 | 1.8 | 21.7 | 1 | 1 | – | – | – | – | – |
2010 | 11,397 | 5.9 | 28.2 | 1.42 (1.29–1.55) | 1.42 (1.29–1.56) | – | – | – | – | – |
2011 | 28,463 | 14.6 | 26.8 | 1.32 (1.22–1.44) | 0.94 (0.83–1.07) | 6484 | 3.4 | 31.8 | 1 | 1 |
2012 | 59,371 | 30.5 | 32.6 | 1.74 (1.61–1.89) | 1.14 (1.01–1.30) | 74,231 | 39.3 | 34.8 | 1.15 (1.09–1.21) | 1.09 (1.04–1.16) |
2013 | 64,134 | 33.0 | 22.2 | 1.03 (0.95–1.21) | 0.62 (0.55–0.70) | 78,172 | 41.4 | 21.4 | 0.58 (0.55–0.62) | 0.52 (0.49–0.55) |
2014b | 27,477 | 14.1 | 30.5 | 1.59 (1.46–1.72) | 0.75 (0.65–0.86) | 30,003 | 15.9 | 27.5 | 0.81 (0.77–0.86) | 0.60 (0.55–0.65) |
State | ||||||||||
Massachusetts | 136,351 | 70.1 | 29.2 | 1 | 1 | 151,877 | 80.4 | 29.5 | 1 | 1 |
Maine | 24,761 | 12.7 | 24.4 | 0.78 (0.76–0.81) | 0.76 (0.73–0.78) | 15,160 | 8.0 | 19.3 | 0.57 (0.55–0.60) | 0.59 (0.56–0.61) |
New Hampshire | 33,295 | 17.1 | 23.2 | 0.73 (0.71–0.75) | 0.67 (0.65–0.69) | 21,853 | 11.6 | 23.6 | 0.74 (0.71–0.76) | 0.72 (0.70–0.75) |